FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2273870928> ?p ?o ?g. }

• W2273870928 endingPage "17" @default.
• W2273870928 startingPage "11" @default.
• W2273870928 abstract "Background The aim of this study is to assess the safety and the short-term results of endovascular treatment of common iliac artery (CIA) aneurysms using the new GORE EXCLUDER iliac branch endoprosthesis (IBE) device. Methods The study is a retrospective with prospective follow-up nonrandomized, single-arm evaluation. Patients with a CIA aneurysm (diameter >30 mm) extending to the iliac bifurcation underwent endovascular treatment with the Gore IBE. Anatomic and procedural data were collected. Computed tomography angiography (CTA) was performed within the 30 days after the procedure and every 6 month. Thirty-day and at least 6-months outcomes were investigated. Results From February 2014 to December 2014, 10 male patients with aneurysmal CIA (mean age 75 years old) underwent consecutive endovascular treatment with the Gore IBE. The CIA aneurysm (mean diameter 43.2 mm, range 32–49) treated with the Gore IBE was associated with an abdominal aortic aneurysm (AAA) in 5 patients. One patient had a previous AAA open repair. CIA aneurysm was bilateral in 5 patients. Preliminary procedure of internal iliac artery embolization was performed in 3 patients. Technical success rate of the Gore IBE implantation was 100% with a median fluoroscopy time of 35 min (range 12–64, ±16) and median contrast load of 150 mL (range 100–250, ±45). No perioperative complications were observed. Median length of stay was 4 days (range 3–7, ±2). One aortic type Ia endoleak was observed on the postoperative CT scan requiring an aortic extension at day 3. Branch patency was observed in all 10 patients at 1 month and 9 patients at 6 month. All CIA aneurysms were excluded without type Ib or type III endoleak. Conclusions The technical success and short-term results demonstrate encouraging results and clinical benefits of the new GORE EXCLUDER IBE. A longer follow-up is needed to assess midterm and long-term results. The aim of this study is to assess the safety and the short-term results of endovascular treatment of common iliac artery (CIA) aneurysms using the new GORE EXCLUDER iliac branch endoprosthesis (IBE) device. The study is a retrospective with prospective follow-up nonrandomized, single-arm evaluation. Patients with a CIA aneurysm (diameter >30 mm) extending to the iliac bifurcation underwent endovascular treatment with the Gore IBE. Anatomic and procedural data were collected. Computed tomography angiography (CTA) was performed within the 30 days after the procedure and every 6 month. Thirty-day and at least 6-months outcomes were investigated. From February 2014 to December 2014, 10 male patients with aneurysmal CIA (mean age 75 years old) underwent consecutive endovascular treatment with the Gore IBE. The CIA aneurysm (mean diameter 43.2 mm, range 32–49) treated with the Gore IBE was associated with an abdominal aortic aneurysm (AAA) in 5 patients. One patient had a previous AAA open repair. CIA aneurysm was bilateral in 5 patients. Preliminary procedure of internal iliac artery embolization was performed in 3 patients. Technical success rate of the Gore IBE implantation was 100% with a median fluoroscopy time of 35 min (range 12–64, ±16) and median contrast load of 150 mL (range 100–250, ±45). No perioperative complications were observed. Median length of stay was 4 days (range 3–7, ±2). One aortic type Ia endoleak was observed on the postoperative CT scan requiring an aortic extension at day 3. Branch patency was observed in all 10 patients at 1 month and 9 patients at 6 month. All CIA aneurysms were excluded without type Ib or type III endoleak. The technical success and short-term results demonstrate encouraging results and clinical benefits of the new GORE EXCLUDER IBE. A longer follow-up is needed to assess midterm and long-term results." @default.
• W2273870928 created "2016-06-24" @default.
• W2273870928 creator A5023121345 @default.
• W2273870928 creator A5025158017 @default.
• W2273870928 creator A5046390271 @default.
• W2273870928 creator A5060752260 @default.
• W2273870928 creator A5066439342 @default.
• W2273870928 creator A5072015282 @default.
• W2273870928 creator A5083022111 @default.
• W2273870928 date "2016-05-01" @default.
• W2273870928 modified "2023-09-30" @default.
• W2273870928 title "Preliminary Experience with the GORE® EXCLUDER® Iliac Branch Endoprosthesis for Common Iliac Aneurysm Endovascular Treatment" @default.
• W2273870928 cites W1964062099 @default.
• W2273870928 cites W1981200083 @default.
• W2273870928 cites W1985145920 @default.
• W2273870928 cites W1985346516 @default.
• W2273870928 cites W2005132474 @default.
• W2273870928 cites W2014764096 @default.
• W2273870928 cites W2017650214 @default.
• W2273870928 cites W2026658375 @default.
• W2273870928 cites W2051883343 @default.
• W2273870928 cites W2061309336 @default.
• W2273870928 cites W2061465033 @default.
• W2273870928 cites W2062544364 @default.
• W2273870928 cites W2063395391 @default.
• W2273870928 cites W2070299095 @default.
• W2273870928 cites W2078786267 @default.
• W2273870928 cites W2110972829 @default.
• W2273870928 cites W2115549656 @default.
• W2273870928 cites W2118556563 @default.
• W2273870928 cites W2130442582 @default.
• W2273870928 cites W2131739981 @default.
• W2273870928 cites W2136436338 @default.
• W2273870928 cites W2142732978 @default.
• W2273870928 cites W2144378806 @default.
• W2273870928 cites W2316672465 @default.
• W2273870928 cites W2335472103 @default.
• W2273870928 cites W4236704839 @default.
• W2273870928 doi "https://doi.org/10.1016/j.avsg.2015.12.003" @default.
• W2273870928 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26808286" @default.
• W2273870928 hasPublicationYear "2016" @default.
• W2273870928 type Work @default.
• W2273870928 sameAs 2273870928 @default.
• W2273870928 citedByCount "28" @default.
• W2273870928 countsByYear W22738709282016 @default.
• W2273870928 countsByYear W22738709282017 @default.
• W2273870928 countsByYear W22738709282018 @default.
• W2273870928 countsByYear W22738709282019 @default.
• W2273870928 countsByYear W22738709282020 @default.
• W2273870928 countsByYear W22738709282021 @default.
• W2273870928 countsByYear W22738709282022 @default.
• W2273870928 countsByYear W22738709282023 @default.
• W2273870928 crossrefType "journal-article" @default.
• W2273870928 hasAuthorship W2273870928A5023121345 @default.
• W2273870928 hasAuthorship W2273870928A5025158017 @default.
• W2273870928 hasAuthorship W2273870928A5046390271 @default.
• W2273870928 hasAuthorship W2273870928A5060752260 @default.
• W2273870928 hasAuthorship W2273870928A5066439342 @default.
• W2273870928 hasAuthorship W2273870928A5072015282 @default.
• W2273870928 hasAuthorship W2273870928A5083022111 @default.
• W2273870928 hasConcept C126838900 @default.
• W2273870928 hasConcept C141071460 @default.
• W2273870928 hasConcept C167135981 @default.
• W2273870928 hasConcept C2776035437 @default.
• W2273870928 hasConcept C2776098176 @default.
• W2273870928 hasConcept C2776543907 @default.
• W2273870928 hasConcept C2776805002 @default.
• W2273870928 hasConcept C2779959501 @default.
• W2273870928 hasConcept C2779993416 @default.
• W2273870928 hasConcept C2780643987 @default.
• W2273870928 hasConcept C2781347138 @default.
• W2273870928 hasConcept C2781460036 @default.
• W2273870928 hasConcept C3018386432 @default.
• W2273870928 hasConcept C31174226 @default.
• W2273870928 hasConcept C71924100 @default.
• W2273870928 hasConceptScore W2273870928C126838900 @default.
• W2273870928 hasConceptScore W2273870928C141071460 @default.
• W2273870928 hasConceptScore W2273870928C167135981 @default.
• W2273870928 hasConceptScore W2273870928C2776035437 @default.
• W2273870928 hasConceptScore W2273870928C2776098176 @default.
• W2273870928 hasConceptScore W2273870928C2776543907 @default.
• W2273870928 hasConceptScore W2273870928C2776805002 @default.
• W2273870928 hasConceptScore W2273870928C2779959501 @default.
• W2273870928 hasConceptScore W2273870928C2779993416 @default.
• W2273870928 hasConceptScore W2273870928C2780643987 @default.
• W2273870928 hasConceptScore W2273870928C2781347138 @default.
• W2273870928 hasConceptScore W2273870928C2781460036 @default.
• W2273870928 hasConceptScore W2273870928C3018386432 @default.
• W2273870928 hasConceptScore W2273870928C31174226 @default.
• W2273870928 hasConceptScore W2273870928C71924100 @default.
• W2273870928 hasLocation W22738709281 @default.
• W2273870928 hasLocation W22738709282 @default.
• W2273870928 hasLocation W22738709283 @default.
• W2273870928 hasLocation W22738709284 @default.
• W2273870928 hasOpenAccess W2273870928 @default.
• W2273870928 hasPrimaryLocation W22738709281 @default.
• W2273870928 hasRelatedWork W2036903459 @default.
• W2273870928 hasRelatedWork W2088352857 @default.

• next